> > Gastrointestinal System

Imperan Injection

English Name ：

Imperan Injection

R&D code ：

AAD-094

Product Licence ：

衛署藥製字第005896號

NHI. NO. ：

AC05896212

Ingredients ：

Metoclopramide 5 mg/mL

Dosage Form ：

Injection

Strength ：

2 mL

包裝規格：

50 A

Marketing Status ：

處方用藥

Controlled Drugs ：

NO

Manufacturing Place ：

Taiwan

ATC Code ：

A03FA01

Indications ：

Relief of symptoms associated with acute and recurrent diabetic gastroparesis when oral treatment is not feasible. Prophylaxis of nausea/vomiting associated with emetogenic cancer chemotherapy. Prophylaxis of post-op nausea/vomiting in circumstances where nasogastric suction is undesirable.

Dosage ：

Diabetic gastroparesis (early manifestations): initiate with oral form; (severe symptoms): initiate with IM or IV inj. May give 10mg doses slowly by IV route over a 1–2 minute period. Administration up to 10 days may be needed, at which time oral form may be instituted. Prophylaxis of nausea/vomiting: administer by IV infusion slowly over at least 15mins; give 30mins before chemotherapy and repeat every 2hrs for 2 doses, then every 3hrs for 3 doses. If highly emetogenic drugs used alone or in combination (eg, cisplatin, dacarbazine): give 2mg/kg for initial 2 doses; if less emetogenic drugs: 1mg/kg per dose may suffice. For doses >10mg: dilute in 50mL of a parenteral soln. Prophylaxis of post-op nausea/vomiting: give by IM inj near the end of surgery. Usually 10mg, however, 20mg doses may be used.

NHI. Price. ：

15

NHI. Effective Date ：

100.12.01

Licence Expire Day ：

108/02/19

Product Code ：

4110002100942

產品資訊查詢:https://lmspiq.fda.gov.tw/web/DRPIQ/DRPIQ1000Result?licBaseId=6F99E4D8-3C3F-4931-B795-C41DDE386ED7

Rich Capsules

Escopan Injection